HIGHLIGHTS
- who: Xingyu Li and colleagues from the College of Science, Yunnan Agricultural University, Kunming, China have published the research: Identification of Bioactive Components of Stephania epigaea Lo and Their Potential Therapeutic Targets by UPLC-MS/MS and Network Pharmacology, in the Journal: Evidence-Based Complementary and Alternative Medicine 1-O-u03b2-D-Glucopyranosylsinapate N-methylliriodendronine 3,4-Dihydroxy-DL-phenylalanine TNF Feruloyltyramine of 27/04/2022
- what: This study demonstrated that S. epigaea might exert the desired disease efficacy mainly through twelve components interacting via five essential target proteins. This study provides a base for . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.